All patients = 18 years admitted to the adult Intensive Care Unit.
Conditions
Interventions
None listed
Sponsors
AMC
Eligibility
Inclusion criteria
Inclusion criteria: Patients are included in the study if they are aged 18 years and older and are newly admitted to the ICU during the course of a pre-specified week (7 days).
Exclusion criteria
Exclusion criteria: All patients younger than 18 years old No informed consent in countries where no opt-out procedure applies.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Our objective is to quantify international transfusion practice in ICUs. We will be looking at transfusion and administration of RBCs, platelets, plasma and several coagulation agents (pro-coagulant and anti-fibrinolytic) in correlation to clinical parameters and corresponding laboratory values. Differences within and between regions will be studied. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary objectives will include the following: - To evaluate the effect of physiological triggers on transfusion practice; - To evaluate the effect of transfusion on corresponding hematology laboratory variables; - To compare transfusion practice in different patient subgroups, e.g. septic shock and coronary disease; - To evaluate the association of transfusion thresholds applied and clinical outcomes (e.g. 28-day mortality). | — |
Contacts
Public ContactAlexander Vlaar
Amsterdam UMC, location AMC
Outcome results
None listed